Policy shifts jeopardize the future of medical education in the US

The Trump administration’s Big Beautiful Bill—with its changes to medical education funding and accreditation—represents a radical re-imagining of who becomes a doctor, the values they are taught, and who ultimately benefits from their expertise. At the heart of these changes is a set of financial reforms that threaten to make medical education inaccessible to all but the most privileged. By capping federal student loans for professional degrees at $200 0001—far below the $286 454 average cost at public medical schools and $390 848 at private institutions2—the government would force aspiring doctors to turn to private lenders, who typically offer higher interest rates and less flexible repayment options. The elimination of key programs like the Grad PLUS loan—which covered the full cost of attendance—and the introduction of restrictions that will make it harder for medical residents to take advantage of the Public Service Loan Forgiveness program further compound this burden.1 For many students—particularly those from under-represented or economically disadvantaged backgrounds—these changes will be insurmountable barriers to entry.

The implications of these financial obstacles are profound. The US already faces a looming shortage of physicians, with rural and underserved urban areas bearing the brunt.3 By 2037, the nation is projected to face a shortage of more than 180 000 physicians, including more than 85 000 primary care doctors.4 If only those with substantial personal wealth can afford to train as doctors, the workforce will become less diverse and representative, with reduced ability to meet the needs of a heterogeneous patient population. This is not just an American problem: the US is a major trainer of international medical graduates and a net exporter of medical research and innovation.5 A contraction in the pipeline of US trained physicians will have ripple effects throughout the world, exacerbating global health inequities and stalling progress toward universal health coverage.

Equally concerning are the changes to medical school accreditation, which threaten to politicize and destabilize the standards by which future doctors are trained. An executive order targeting diversity, equity, and inclusion (DEI) initiatives in medical education would allow the federal government to revoke recognition of accrediting bodies that are deemed to be “engaging in unlawful discrimination” related to DEI standards.6 This move mischaracterizes efforts to tackle health inequalities and promote cultural competence as ideological over-reach, rather than essential components of high quality care. If accreditation is redefined to focus solely on narrow metrics divorced from social context,7 the result will be a generation of clinicians who are ill equipped to confront the complex and intersectional realities of medicine.

The attack on DEI in medicine is part of a broader pattern of federal disengagement from the social mission of medical education. Proposed budget cuts to the National Institutes of Health and the Centers for Disease Control and Prevention threaten to stall research on emerging health threats, while the elimination of funding for studies on vaccine hesitancy signals a willingness to undermine scientific inquiry.8 The proposal to dismantle the Department of Education and transfer federal loan servicing to the Small Business Administration9 further underscores the shift from viewing medical education as a public investment to treating it as a private commodity.

The future of American medicine and the global standards by which we train, accredit, and support the next generation of health professionals is under threat. If the US, a leader in medical education and research, abandons its commitment to equity, accessibility, and scientific integrity, other countries may follow. The international medical community must recognize that these policy shifts will likely contribute to the broader erosion of the social contract that underpins healthcare worldwide.

Viewing these developments as the inevitable result of political cycles is a mistake. The medical profession has a responsibility to advocate for its patients and for maintaining the structures that enable them to serve those patients, including through organized lobbying efforts and public testimony against harmful education policies. We must speak out against policies that restrict access to medical education, undermine efforts to reduce health inequalities, and subordinate research to ideology, while simultaneously working to expand scholarship programs and public service loan forgiveness options. We must reaffirm our commitment as a global medical community to a vision of medicine that is inclusive, evidence based, and oriented toward the public good by developing concrete alternatives to these damaging policies.10

The US can’t afford to lose our next generation of doctors. The health of our patients, our communities, and our global society depends on them.